Publications » Antimicrobial stewardship, rapid PCR and STI

12/01/2021Publication

Antimicrobial stewardship, rapid PCR and STI

Significant improvement to patient care and antimicrobial stewardship with appropriate use of antibiotics may be achieved through the use of rapid point-of-care PCR STI testing.

Antimicrobial stewardship, rapid PCR and STI

Challenge

Accurate same-day sexually transmitted infections (STI) diagnostic test results are generally unavailable, leading to syndromic management with high rates of over- and under-treatment, which contributes to antibiotic resistance.
Hypothesis: Might a rapid molecular diagnostic test help clinicians deliver the right treatment to women with STI during a single visit?

Action

Conduct a cross-sectional single-visit study to evaluate the Visby Medical Sexual Health Click Test with respect to:

  • Ease of integration into clinical practice,
  • Acceptance by patients and clinic personnel, and
  • Potential to inform correct treatment decisions.

Result

  1. If integrated efficiently into the clinical workflow, the test would have minimal impact on staff time and visit duration for patients.
  2. Patients strongly agreed that self-collecting the vaginal swab was easy, and they were comfortable waiting up to 30-minutes to get results. Operators reported the device was easy to use. Clinicians valued the rapid results.
  3. Importantly, in 13 of 15 undertreated cases, the Visby Medical test correctly identified the causative pathogen. The test also correctly identified all 33 incidences of over-treatment. This suggests that clinical adoption of the Visby Medical test into primary care clinics could reduce over- and under-treatment of STIs, contributing to improved antimicrobial stewardship.

In addition, the following were observed:

  • Reduced test turnaround time (TAT) from an average of 6 days for Standard of Care (SOC) down to ± 45 minutes for Visby Medical Sexual Health Click test
  • Potential to reduce antibiotic overuse and associated effects on emerging antibiotic-resistant bacteria
  • Potential to reduce delays in correctly identifying infected individuals by delivering test results in a single visit
  • Improved physician and patient satisfaction

Conclusion

The biggest potential benefit of using a point of care molecular / polymerase chain reaction (PCR) test was the rapid turnaround time for delivery of the test results in a single visit. This would allow clinicians to treat patients based on the test results as opposed to empiric (presumptive) treatment, thereby reducing over- and under- treatment and reduced misuse of antibiotics.

Rate of patients over- or under-treated 

Rate of patients over- or under-treated

Test TAT

Test Turnaround Time

 

See the full article here.

Read more articles & insights

02/21/2024Press Release

CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today that it will award biotechnology company Visby Medical of San Jose, California, up to $1.8 million to develop a portable polymerase chain reaction (PCR) test that can detect gonorrhea and assess its susceptibility to ciprofloxacin.

Read More
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

12/01/2023Viewpoint

Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares

As the chill in the air intensifies, healthcare systems worldwide brace themselves for a seasonal upswing in respiratory illnesses. This year, the situation is exacerbated by the continuing threat of COVID-19 alongside the potential resurgence of seasonal influenza (Flu A and Flu B).

Read More
Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares

11/18/2023Viewpoint

A Case Study on the Importance of Testing: When SARS-CoV-2 Meets Influenza A

In the setting of a global pandemic, the specter of SARS-CoV-2 infection has understandably dominated the differential diagnosis for respiratory symptoms. However, it is crucial to remember that other respiratory pathogens continue to circulate, potentially leading to varied clinical presentations in patients who share the same exposure or living environment.

Read More
A Case Study on the Importance of Testing: When SARS-CoV-2 Meets Influenza A

05/11/2023Viewpoint

Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.

Read More
Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected